What’s Next for Cell and Gene Therapies in 2023 and Beyond

This workshop will feature leading executives in the ATMP space who will discuss a number of topics including future technologies, the current investment environment and what innovators can do to mitigate growing market pressures. The session will also touch upon resolving manufacturing and regulatory bottlenecks as the sector moves towards commercialization, as well as the evolution of reimbursement payment models.
Chair:
Anshul Mangal, President, Precision ADVANCE and Project Farma
Speakers:
Stewart Abbot, Ph.D., Chief Scientific Officer, Turnstone Biologics
Andrew Knudten, Chief Operating Officer, Jaguar Gene Therapy
Laura Lande-Diner, Ph.D., Chief Business Officer, Satellite Bio
Robert Peters, Ph.D., Chief Scientific Officer, Ensoma
Deb Phippard, Ph.D., Chief Scientific Officer, Precision for Medicine

[@bikojalal3120]

Is there any gene therapy for Ethylmalonic encephalopathy?

[@Have0973]

My daughter been on the list for a year now and the person that is in charge of recruiting in houston for Gene therapy for rett I can't even get a hold of any one at all I been calling there is 5 spots available and the doctors can't even call us and talk to us at all why is it so Hurd for the neurologist to call and see where we stand on recruiting our children they just ignore me not calling back and not giving me any info
Just sad 😔
We believe in doctors but they take our kids as jokes and it hurts how simply they don't care as simple as a phone call